Member Info for EyesOfBlue

24 February 2023

Belluscura plc

("Belluscura" or the "Company")

Belluscura's X-PLOR® portable oxygen concentrator now marketed through GoodRx®

Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that the X-PLOR portable oxygen concentrator ("POC") is now marketed in the US through GoodRx, Inc. www.goodrx.com The X-PLOR will be the first medical device in its field marketed by GoodRx, Inc.

GoodRx, Inc (Nasdaq: GDRX) is a leading digital healthcare platform that makes healthcare affordable and convenient for all Americans. The company offers consumers free access to transparent and lower prices for branded and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. Since 2011, GoodRx has helped consumers save over $45 billion and has been one of the most downloaded medical apps over the past decade.

Commenting on the new marketing portal, Robert Rauker, Chief Executive Officer, Belluscura plc, said:

"In our continued goal of broadening product distribution and making supplemental oxygen more accessible to people throughout the US, we are excited to have the X-PLOR marketed through GoodRx, a recognized leader in making healthcare more accessible and affordable in the US."

23rd Feb in 2022. Will be interesting to see the numbers following the recent trading update.

I think those interested in reading the note may need to Google “SP ANGEL TEK CAPITAL” or similar, sorry!

URL will prob get corrupted by this daft site, but here’s a link to the NON-INDEPENDENT research from SP Angel.

https://*********************/companies/uk/tekcapital-plc/research/sp-angel/sp-angel-spec-sits-update-post-placing-tek-ln-/7_2023022304053278160

Cheers for your valuable input Puma, that’s the spirit.

Molten Ventures plc (LSE: GROW, Euronext Dublin: GRW), a leading venture capital firm investing in and developing high growth digital technology businesses, will be hosting an Investor Day at 9.00am today for investors and sell-side analysts.

The event gathers some of the CEOs from across the Molten portfolio and offers an opportunity to learn about the trends in technology across Europe and the key advancements in the sector.

No new material disclosures will be made during the event. A recording of Chief Executive Officer Martin Davis’s keynote presentation will be made available on the IR website on 17th February.

RCP discussed in much greater depth on Citywire in its own long running thread.

https://moneyforums.citywire.com/yaf_postst9054p41_RIT-capital-partners.aspx

I initially assumed that US Salt would be another regional, mid-West or whatever distributor. But I was very wrong it seems.

“US Salt, LLC is currently responsible for producing and distributing over 90% of the private label, round can salt business in the United States.“

This could actually be quite significant.

I managed to make a small profit there! More than I’ve ever done here!! JR got more and more desperate for absolutely any news each day, I was actually quite worried he might be having dark thoughts (seriously).

Oh dear. LSE’s very own perma-simpleton seems to have found his way here from Sirius Minerals, where he’s probably still waiting for “news” and “great start to the day so far” and all his other copied and pasted “lift off” ****e.

Really positive. Let’s face it, any timing for their IPO can only be better than the LUCY one so I’m cautiously optimistic.

A selection of today’s trades. Someone playing games or falling asleep on their keyboard whilst drunk? (!)

23 16:21:28 591.18 205,961 Unknown* 1m O
30-Jan-23 16:13:38 591.18 -205,961 Unknown* -1m O
30-Jan-23 16:02:21 590.00 -105,961 Unknown* -625.17k O
30-Jan-23 15:48:56 590.00 -100,000 Unknown* -590.00k O
30-Jan-23 16:13:38 591.18 205,961 Unknown* 1m O
30-Jan-23 16:04:29 596.00 5 Buy* 29.80 O
30-Jan-23 16:02:21 590.00 105,961 Sell* 625.17k O
30-Jan-23 15:49:18 591.563 147 Sell* 869.60 O
30-Jan-23 15:48:56 590.00 100,000 Sell* 590.00k O

Dull and reliable like DLG! Hopefully more reliable than that !!

The economic environment for building and selling houses in the uk is dreadful. I got out of TW and PSN (a little prematurely) a few weeks back for this reason. In part guided by what happened at DLG where the long-standing final dividend was cancelled and the SP fell by 25% in something of a panic sell.

Pretty much as expected really? Strong 2022, really poor outlook for 2023 but one that isn’t accompanied by any estimates.

Re divs not showing on Barclays, I thought mine hadn’t been paid into my ii account. It actually has, I’d just missed the currency drop down at the top of my transactions screen! Changing it to $ showed the DEC dividend (credited to accounts in USD of course). Ignore me if you’ve tried that already :o)

A vote of confidence I think. Can only be positive?

Sorry, ignore me, interims are 21/11 from the last RNS. DOH!!

Last year there was a trading update on 4/11 and interim results on 29/11.

This year the update was the same week on 2/11 … so I assume interims could well be Monday 28/11. Anyone disagree? Reason being I expect profit taking to continue this week, especially with today’s inflation figure of 11.1%, but a significant uplift when the interims reinforce the 830p NAV and good profitability.

NAV is 830p. …

Highlights for the period:

· Gross Portfolio Value (unaudited) is expected to be not less than £1,450 million (30 September 2021: £1,350 million; 31 March 2022: £1,532 million)

· Underlying Gross Portfolio decrease in fair value (unaudited) of approximately 17% at constant currency. Net decline of 12% due to offsetting currency tailwinds of approximately 5%

· Valuations calibrated to reflect public market peers leading to a reduction in Enterprise Value ("EV") in the Core portfolio on average of 35%, leading to fair value reductions (before currency movements) of 17%, with preference share protection limiting the downside

· Portfolio well-funded with more than 75% of the Core with over 18 months of cash runway and revenues continue to grow at an average for the Core of over 60% with forecast growth of 70% for 2023

· NAV per share is expected to be not less than 830p (30 September 2021: 887p; 31 March 2022: 937p)